{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:40:37Z","timestamp":1783118437926,"version":"3.54.6"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s11596-024-2853-7","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:16:10Z","timestamp":1713240970000},"page":"333-345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["BMSC-derived Exosomes Ameliorate Peritoneal Dialysis-associated Peritoneal Fibrosis via the Mir-27a-3p\/TP53 Pathway"],"prefix":"10.1007","volume":"44","author":[{"given":"Jun-li","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-nan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-wen","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"issue":"9981","key":"2853_CR1","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet, 2015,385(9981):1975\u20131982","journal-title":"Lancet"},{"issue":"3","key":"2853_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.ajkd.2020.05.032","volume":"77","author":"Y Cho","year":"2021","unstructured":"Cho Y, Bello AK, Levin A, et al. Peritoneal Dialysis Use and Practice Patterns: An International Survey Study. Am J Kidney Dis, 2021,77(3):315\u2013325","journal-title":"Am J Kidney Dis"},{"key":"2853_CR3","doi-asserted-by":"crossref","unstructured":"Holmes CJ, Faict D. Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies. Kidney Int Suppl, 2003,(88):S50-S56","DOI":"10.1046\/j.1523-1755.2003.08806.x"},{"issue":"7","key":"2853_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrneph.2013.99","volume":"9","author":"RT Krediet","year":"2013","unstructured":"Krediet RT, Struijk DG. Peritoneal changes in patients on long-term peritoneal dialysis. Nat Rev Nephrol, 2013,9(7):419\u2013429","journal-title":"Nat Rev Nephrol"},{"issue":"1\u20133","key":"2853_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000368972","volume":"39","author":"I Teitelbaum","year":"2015","unstructured":"Teitelbaum I. Ultrafiltration failure in peritoneal dialysis: a pathophysiologic approach. Blood Purif, 2015,39(1\u20133):70\u201373","journal-title":"Blood Purif"},{"issue":"22","key":"2853_CR6","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.3390\/ijms20225765","volume":"20","author":"RM Jagirdar","year":"2019","unstructured":"Jagirdar RM, Bozikas A, Zarogiannis SG, et al. Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options. Int J Mol Sci, 2019,20(22):5765","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2853_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5966\/sctm.2015-0001","volume":"5","author":"YP Fan","year":"2016","unstructured":"Fan YP, Hsia CC, Tseng KW, et al. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton\u2019s Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis. Stem Cells Transl Med, 2016,5(2):235\u2013247","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"2853_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ki.2013.81","volume":"84","author":"T Ueno","year":"2013","unstructured":"Ueno T, Nakashima A, Doi S, et al. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta1 signaling. Kidney Int, 2013,84(2):297\u2013307","journal-title":"Kidney Int"},{"issue":"1","key":"2853_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13287-021-02273-1","volume":"12","author":"K Nagasaki","year":"2021","unstructured":"Nagasaki K, Nakashima A, Tamura R, et al. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis. Stem Cell Res Ther, 2021,12(1):203","journal-title":"Stem Cell Res Ther"},{"issue":"48","key":"2853_CR10","doi-asserted-by":"publisher","first-page":"83872","DOI":"10.18632\/oncotarget.20040","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Wang L, Xu L, et al. Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition. Oncotarget, 2017,8(48):83872\u201383889","journal-title":"Oncotarget"},{"issue":"2","key":"2853_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/0886022X.2015.1127741","volume":"38","author":"Y Morishita","year":"2016","unstructured":"Morishita Y, Ookawara S, Hirahara I, et al. HIF-1alpha mediates Hypoxia-induced epithelial-mesenchymal transition in peritoneal mesothelial cells. Ren Fail, 2016,38(2):282\u2013289","journal-title":"Ren Fail"},{"key":"2853_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fimmu.2012.00192","volume":"3","author":"JS Chen","year":"2012","unstructured":"Chen JS, Wong VW, Gurtner GC. Therapeutic potential of bone marrow-derived mesenchymal stem cells for cutaneous wound healing. Front Immunol, 2012,3:192","journal-title":"Front Immunol"},{"issue":"8","key":"2853_CR13","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/cells8080886","volume":"8","author":"Y Han","year":"2019","unstructured":"Han Y, Li X, Zhang Y, et al. Mesenchymal Stem Cells for Regenerative Medicine. Cells, 2019,8(8):886","journal-title":"Cells"},{"key":"2853_CR14","doi-asserted-by":"publisher","first-page":"34842","DOI":"10.1038\/srep34842","volume":"6","author":"K Nagaishi","year":"2016","unstructured":"Nagaishi K, Mizue Y, Chikenji T, et al. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci Rep, 2016,6:34842","journal-title":"Sci Rep"},{"key":"2853_CR15","doi-asserted-by":"publisher","first-page":"112784","DOI":"10.1016\/j.ejmech.2020.112784","volume":"207","author":"M Li","year":"2020","unstructured":"Li M, Li S, Du C, et al. Exosomes from different cells: Characteristics, modifications, and therapeutic applications. Eur J Med Chem, 2020,207:112784","journal-title":"Eur J Med Chem"},{"issue":"1","key":"2853_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/stem.2922","volume":"37","author":"L Murray","year":"2019","unstructured":"Murray L, Krasnodembskaya AD. Concise Review: Intercellular Communication Via Organelle Transfer in the Biology and Therapeutic Applications of Stem Cells. Stem Cells, 2019,37(1):14\u201325","journal-title":"Stem Cells"},{"issue":"3","key":"2853_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s13577-022-00680-x","volume":"35","author":"C Fan","year":"2022","unstructured":"Fan C, Wang Q, Chen Y, et al. Exosomes derived from bone mesenchymal stem cells attenuate myocardial fibrosis both in vivo and in vitro via autophagy activation: the key role of miR-199a-3p\/mTOR pathway. Hum Cell, 2022,35(3):817\u2013835","journal-title":"Hum Cell"},{"issue":"2","key":"2853_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-022-09714-4","volume":"39","author":"J Ma","year":"2023","unstructured":"Ma J, Li Y, Chen M, et al. hMSCs-derived exosome circCDK13 inhibits liver fibrosis by regulating the expression of MFGE8 through miR-17-5p\/KAT2B. Cell Biol Toxicol, 2023,39(2):1\u201322","journal-title":"Cell Biol Toxicol"},{"issue":"3","key":"2853_CR19","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1080\/21655979.2021.2023799","volume":"13","author":"C Sun","year":"2022","unstructured":"Sun C, Shi C, Duan X, et al. Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4. Bioengineered, 2022,13(3):5915\u20135927","journal-title":"Bioengineered"},{"key":"2853_CR20","doi-asserted-by":"publisher","first-page":"2687807","DOI":"10.1155\/2022\/2687807","volume":"2022","author":"L Xu","year":"2022","unstructured":"Xu L, Fan Y, Wu L, et al. Exosomes from Bone Marrow Mesenchymal Stem Cells with Overexpressed Nrf2 Inhibit Cardiac Fibrosis in Rats with Atrial Fibrillation. Cardiovasc Ther, 2022,2022:2687807","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"2853_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12974-018-1053-4","volume":"15","author":"L Yao","year":"2018","unstructured":"Yao L, Ye Y, Mao H, et al. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson\u2019s disease. J Neuroinflammation, 2018,15(1):13","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2853_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3892\/ijo.2016.3533","volume":"49","author":"J Hu","year":"2016","unstructured":"Hu J, Shan Z, Hu K, et al. miRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1. Int J Oncol, 2016,49(1):325\u2013335","journal-title":"Int J Oncol"},{"issue":"4","key":"2853_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1136\/jclinpath-2016-204031","volume":"70","author":"A Jaca","year":"2017","unstructured":"Jaca A, Govender P, Locketz M, et al. The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer. J Clin Pathol, 2017,70(4):331\u2013356","journal-title":"J Clin Pathol"},{"issue":"10","key":"2853_CR24","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1002\/hed.25381","volume":"40","author":"C Domingues","year":"2018","unstructured":"Domingues C, Serambeque BP, Laranjo CM, et al. Epithelial-mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer. Head Neck, 2018,40(10):2304\u20132313.","journal-title":"Head Neck"},{"key":"2853_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12882-015-0039-z","volume":"16","author":"F Lin","year":"2015","unstructured":"Lin F, Wu X, Zhang H, et al. A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis. BMC Nephrol, 2015,16:48","journal-title":"BMC Nephrol"},{"issue":"4","key":"2853_CR26","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1111\/jcmm.14029","volume":"23","author":"X Li","year":"2019","unstructured":"Li X, Liu H, Sun L, et al. MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor. J Cell Mol Med, 2019,23(4):2372\u20132383","journal-title":"J Cell Mol Med"},{"key":"2853_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cca.2016.11.020","volume":"464","author":"CC Szeto","year":"2017","unstructured":"Szeto CC, Chow KM, Kwan BC, et al. Peritoneal dialysis effluent miR-21 and miR-589 levels correlate with longitudinal change in peritoneal transport characteristics. Clin Chim Acta, 2017,464:106\u2013112","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2853_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-022-01615-8","volume":"21","author":"Y Xi","year":"2022","unstructured":"Xi Y, Shen Y, Wu D, et al. CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p. Mol Cancer, 2022,21(1):145","journal-title":"Mol Cancer"},{"issue":"4","key":"2853_CR29","doi-asserted-by":"publisher","first-page":"e12628","DOI":"10.1111\/cpr.12628","volume":"52","author":"D Guo","year":"2019","unstructured":"Guo D, Li Y, Chen Y, et al. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1\/LIMK1\/COFILIN1 pathway. Cell Prolif, 2019,52(4):e12628","journal-title":"Cell Prolif"},{"issue":"12","key":"2853_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41581-022-00623-7","volume":"18","author":"A K Bello","year":"2022","unstructured":"Bello A K, Okpechi I G, Osman M A, et al. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol, 2022,18(12):779\u2013793","journal-title":"Nat Rev Nephrol"},{"key":"2853_CR31","doi-asserted-by":"publisher","first-page":"709204","DOI":"10.3389\/fcell.2021.709204","volume":"9","author":"C Gu","year":"2021","unstructured":"Gu C, Feng J, Waqas A, et al. Technological Advances of 3D Scaffold-Based Stem Cell\/Exosome Therapy in Tissues and Organs. Front Cell Dev Biol, 2021,9:709204","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2853_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10456-015-9486-1","volume":"19","author":"Y Fang","year":"2016","unstructured":"Fang Y, Garnier D, Lee TH, et al. PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells. Angiogenesis, 2016,19(1):25\u201338","journal-title":"Angiogenesis"},{"key":"2853_CR33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.addr.2020.04.011","volume":"159","author":"S Vanherle","year":"2020","unstructured":"Vanherle S, Haidar M, Irobi J, et al. Extracellular vesicle-associated lipids in central nervous system disorders. Adv Drug Deliv Rev, 2020,159:322\u2013331","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2853_CR34","doi-asserted-by":"publisher","first-page":"F560","DOI":"10.1152\/ajprenal.00242.2019","volume":"317","author":"R Sabaratnam","year":"2019","unstructured":"Sabaratnam R, Geertsen L, Skjodt K, et al. In human nephrectomy specimens, the kidney level of tubular transport proteins does not correlate with their abundance in urinary extracellular vesicles. Am J Physiol Renal Physiol, 2019,317(3):F560\u2013F571","journal-title":"Am J Physiol Renal Physiol"},{"key":"2853_CR35","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3389\/fphys.2018.01815","volume":"9","author":"R T Krediet","year":"2018","unstructured":"Krediet R T. Ultrafiltration Failure Is a Reflection of Peritoneal Alterations in Patients Treated With Peritoneal Dialysis. Front Physiol, 2018,9:1815","journal-title":"Front Physiol"},{"issue":"145","key":"2853_CR36","first-page":"271","volume":"26","author":"K Yanai","year":"2018","unstructured":"Yanai K, Ishii H, Aomatsu A, et al. MicroRNAs in peritoneal fibrosis: a systematic review. Discov Med, 2018,26(145):271\u2013280","journal-title":"Discov Med"},{"issue":"1","key":"2853_CR37","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.1038\/s41598-017-05836-6","volume":"7","author":"HS Shin","year":"2017","unstructured":"Shin HS, Ko J, Kim DA, et al. Metformin ameliorates the Phenotype Transition of Peritoneal Mesothelial Cells and Peritoneal Fibrosis via a modulation of Oxidative Stress. Sci Rep, 2017,7(1):5690","journal-title":"Sci Rep"},{"issue":"2","key":"2853_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/2211-5463.12182","volume":"7","author":"S Ji","year":"2017","unstructured":"Ji S, Deng H, Jin W, et al. Beta-catenin participates in dialysate-induced peritoneal fibrosis via enhanced peritoneal cell epithelial-to-mesenchymal transition. FEBS Open Bio, 2017,7(2):265\u2013273","journal-title":"FEBS Open Bio"},{"key":"2853_CR39","doi-asserted-by":"publisher","first-page":"4150656","DOI":"10.1155\/2019\/4150656","volume":"2019","author":"SA Sung","year":"2019","unstructured":"Sung SA, Kim DH, Oh KH, et al. The Role of Cathepsin B in Peritoneal Fibrosis due to Peritoneal Dialysis. Int J Nephrol, 2019,2019:4150656","journal-title":"Int J Nephrol"},{"issue":"4","key":"2853_CR40","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1046\/j.1523-1755.2003.00861.x","volume":"63","author":"A H Yang","year":"2003","unstructured":"Yang A H, Chen JY, Lin JK. Myofibroblastic conversion of mesothelial cells. Kidney Int, 2003,63(4):1530\u20131539","journal-title":"Kidney Int"},{"issue":"6","key":"2853_CR41","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest, 2009,119(6):1420\u20131428","journal-title":"J Clin Invest"},{"key":"2853_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s11658-019-0157-x","volume":"24","author":"JL Zhao","year":"2019","unstructured":"Zhao JL, Guo MZ, Zhu JJ, et al. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1). Cell Mol Biol Lett, 2019,24:32","journal-title":"Cell Mol Biol Lett"},{"key":"2853_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.yjmcc.2019.12.010","volume":"139","author":"ME Haywood","year":"2020","unstructured":"Haywood ME, Cocciolo A, Porter KF, et al. Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53. J Mol Cell Cardiol, 2020,139:124\u2013134","journal-title":"J Mol Cell Cardiol"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2853-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-024-2853-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2853-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T06:14:58Z","timestamp":1718864098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-024-2853-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2853"],"URL":"https:\/\/doi.org\/10.1007\/s11596-024-2853-7","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"9 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}